The strongly diabetogenic effect of GCs is caused by increased insulin resistance, driven primarily by increased hepatic gluconeogenesis, lipolysis, and elevated circulating free fatty acids (35)
Without a provider review, these contraindications may not be identified before treatment begins
36 Moreover, GLP-1 RAs improve lipid profiles by decreasing serum cholesterol and triglyceride levels and increasing high-density lipoprotein (HDL) levels contributing to cardiovascular protection
Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
Mechanisms of activation of mouse and human enteroendocrine cells by nutrients
Activation of GLP-1R by GLP-1 or other exogenous agonists, including exendin-4 and liraglutide, decreases inflammatory responses in several animal models like rat heart and whole animal model